Both in Pharmaceuticals
Apimeds Pharmaceuticals US vs InMed Pharmaceuticals
Over the past year APUS returned −73.6% and INM returned −39.4%; their daily moves had a correlation of 0.12.
APUS −73.6% INM −39.4%Growth of $1, one year, split-adjusted
| Metric | APUS | INM |
|---|---|---|
| Price | $5.02 | $1.38 |
| Market cap | $7.6M | $7.6M |
| Today | −21.44% | +1.10% |
| 1 month | +29.7% | −0.4% |
| 6 months | −71.3% | +123.6% |
| Year to date | −69.4% | +29.7% |
| 1 year | — | −37.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 3.9× |
| Net cash | -$8.6M | $2.2M |
| Dividend yield | — | — |
| Volatility (60d) | 727.8% | 59.6% |
| Short % of float | 0.1% | 0.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).